OPRIS D

Last name: OPRIS D

2022 (v1)

Publication

Metadata-only

Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trial.

Hartman L El Alili M Cutolo M

No description

Uploaded on: February 14, 2024
2018 (v1)

Publication

Metadata-only

Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial.

Hartman L Rasch LA Klausch T

Rheumatoid arthritis (RA) is a chronic inflammatory disease of the joints affecting 1% of the world population. It has major impact on patients through disability and associated comorbidities. Current treatment strategies have considerably improved the prognosis, but recent innovations (especially biologic drugs and the new class of so-called...

Uploaded on: April 14, 2023
2011 (v1)

Publication

Metadata-only

"To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity.

Cappelli S Bellando Randone S Martinović D

MCTD is a distinct clinical entity but it is evident that a subgroup of patients may evolve into another CTD during disease progression. Initial clinical features and autoantibodies can be useful to predict disease evolution.

Uploaded on: April 14, 2023
2017 (v1)

Publication

Metadata-only

Mapping and predicting mortality from systemic sclerosis.

Elhai M Meune C Boubaya M

No description

Uploaded on: April 14, 2023

OPRIS D

Recent uploads